MEP10109A - Derivatives of pyrrolizine, indolizine and quinolizine, preparation thereof and therapeutic use thereof - Google Patents

Derivatives of pyrrolizine, indolizine and quinolizine, preparation thereof and therapeutic use thereof

Info

Publication number
MEP10109A
MEP10109A MEP-101/09A MEP10109A MEP10109A ME P10109 A MEP10109 A ME P10109A ME P10109 A MEP10109 A ME P10109A ME P10109 A MEP10109 A ME P10109A
Authority
ME
Montenegro
Prior art keywords
alkyl
pyridin
thi
therapeutic use
pyrrolizine
Prior art date
Application number
MEP-101/09A
Other languages
Bosnian (bs)
English (en)
Croatian (hr)
Inventor
Gihad Dargazanli
Genevieve Estenne-Bouhtou
Florence Medaisko
Maria Carmen Renones
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of MEP10109A publication Critical patent/MEP10109A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Indole Compounds (AREA)
MEP-101/09A 2006-09-22 2007-09-21 Derivatives of pyrrolizine, indolizine and quinolizine, preparation thereof and therapeutic use thereof MEP10109A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0608348A FR2906251B1 (fr) 2006-09-22 2006-09-22 Derives de pyrrolizine, indolizine et quinolizine, leur preparation et leur application en therapeutique
PCT/FR2007/001545 WO2008037881A2 (fr) 2006-09-22 2007-09-21 Derives de pyrrolizine, indolizine et quinolizine, leur preparation et leur application en therapeutique.

Publications (1)

Publication Number Publication Date
MEP10109A true MEP10109A (en) 2011-12-20

Family

ID=37897398

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-101/09A MEP10109A (en) 2006-09-22 2007-09-21 Derivatives of pyrrolizine, indolizine and quinolizine, preparation thereof and therapeutic use thereof

Country Status (29)

Country Link
US (2) US7776880B2 (fr)
EP (1) EP2077837A2 (fr)
JP (1) JP2010504311A (fr)
KR (1) KR20090080947A (fr)
CN (1) CN101573113A (fr)
AR (1) AR062896A1 (fr)
AU (1) AU2007301880A1 (fr)
BR (1) BRPI0717100A2 (fr)
CA (1) CA2663080A1 (fr)
CL (1) CL2007002732A1 (fr)
CO (1) CO6160309A2 (fr)
CR (1) CR10658A (fr)
EA (1) EA015974B1 (fr)
FR (1) FR2906251B1 (fr)
GT (1) GT200900061A (fr)
HN (1) HN2009000504A (fr)
IL (1) IL197500A0 (fr)
MA (1) MA30790B1 (fr)
ME (1) MEP10109A (fr)
MX (1) MX2009003083A (fr)
NO (1) NO20091351L (fr)
NZ (1) NZ575573A (fr)
PE (1) PE20081376A1 (fr)
SV (1) SV2009003191A (fr)
TN (1) TN2009000082A1 (fr)
TW (1) TW200819455A (fr)
UY (1) UY30604A1 (fr)
WO (1) WO2008037881A2 (fr)
ZA (1) ZA200901850B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2842804B1 (fr) 2002-07-29 2004-09-03 Sanofi Synthelabo Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
FR2861074B1 (fr) * 2003-10-17 2006-04-07 Sanofi Synthelabo Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
US20120094995A1 (en) * 2009-01-28 2012-04-19 Astrazeneca Ab 2-aza-bicyclo[2.2.1]heptane compounds and uses thereof
WO2010087761A1 (fr) * 2009-01-28 2010-08-05 Astrazeneca Ab Composés 2-aza-bicyclo[2.2.2]octane et leurs utilisations
US8338441B2 (en) 2009-05-15 2012-12-25 Gilead Sciences, Inc. Inhibitors of human immunodeficiency virus replication
US8143273B2 (en) * 2010-06-22 2012-03-27 Hoffman-La Roche Inc. Quinolizidine and indolizidine derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3801636A (en) * 1971-08-13 1974-04-02 Abbott Lab 3,4,5-tri-substituted cinnamides
US4409225A (en) * 1981-03-16 1983-10-11 Beecham Group Limited Substituted benzamides
CA2118798A1 (fr) * 1991-09-12 1993-03-18 Francis D. King Composes azabicycliques utilises comme antagonistes des recepteurs a 5-ht4
CZ284456B6 (cs) 1992-02-15 1998-12-16 Hoechst Aktiengesellschaft Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje
EP1326863A2 (fr) * 2000-09-22 2003-07-16 Ortho-McNeil Pharmaceutical, Inc. Octahydro-indolizines et quinolizines et hexahydro-pyrrolizines
FR2861076B1 (fr) * 2003-10-17 2006-01-06 Sanofi Synthelabo Derives de n-heterocyclymethylbenzamide, leur preparation et leur application en therapeutique
FR2861073B1 (fr) * 2003-10-17 2006-01-06 Sanofi Synthelabo Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
CR10658A (es) 2009-06-24
TW200819455A (en) 2008-05-01
ZA200901850B (en) 2010-06-30
TN2009000082A1 (en) 2010-08-19
CN101573113A (zh) 2009-11-04
JP2010504311A (ja) 2010-02-12
AU2007301880A1 (en) 2008-04-03
BRPI0717100A2 (pt) 2013-10-15
FR2906251A1 (fr) 2008-03-28
MA30790B1 (fr) 2009-10-01
EA015974B1 (ru) 2012-01-30
NZ575573A (en) 2011-12-22
CO6160309A2 (es) 2010-05-20
EP2077837A2 (fr) 2009-07-15
EA200970312A1 (ru) 2009-12-30
SV2009003191A (es) 2009-10-27
HN2009000504A (es) 2011-10-20
PE20081376A1 (es) 2008-11-07
CA2663080A1 (fr) 2008-04-03
AR062896A1 (es) 2008-12-10
US7776880B2 (en) 2010-08-17
FR2906251B1 (fr) 2008-11-07
WO2008037881A2 (fr) 2008-04-03
IL197500A0 (en) 2009-12-24
CL2007002732A1 (es) 2008-04-18
US20090258899A1 (en) 2009-10-15
KR20090080947A (ko) 2009-07-27
NO20091351L (no) 2009-06-22
GT200900061A (es) 2010-06-21
MX2009003083A (es) 2009-04-02
WO2008037881A3 (fr) 2008-05-22
UY30604A1 (es) 2008-05-02
US20100267766A1 (en) 2010-10-21

Similar Documents

Publication Publication Date Title
MEP10109A (en) Derivatives of pyrrolizine, indolizine and quinolizine, preparation thereof and therapeutic use thereof
RS54124B1 (en) COMPOSITIONS AND PROCEDURES FOR TREATMENT OF COLITIS
RS53830B1 (en) INDASOLS SUBSTITUTED BY OXAZOLE AS PI3-KINASE INHIBITORS
CY1111585T1 (el) Ινδολια και θεραπευτικη χρηση αυτων
PE20090290A1 (es) Derivados de pirrolopiridina como inhibidores de bace
BRPI0910871A2 (pt) derivados espirocíclicos como inibidores de histona desacetilase
HRP20070327T3 (en) Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
AR082638A1 (es) Derivados de tetrahidropiran utiles como pesticidas
CO6251283A2 (es) Pirimidil ciclopentanos como inhibidores de proteina cinasa akt
ES2587284T3 (es) 5-Fluoro-pirimidinas 2,4-disustituidas como inhibidores selectivos de CDK9
RS51654B (en) DERIVATIVES OF THE SUBSTITUTED BICYCLIC PIRIMIDONE
MX2010004293A (es) Derivados de 6-aril/heteroalquiloxi benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nuevo uso principalmente como inhibidores de cmet.
RS53326B (en) ANTIMICROBIC UNITS
HRP20120857T1 (hr) Derivati 4-(n-azacikloalkil) anilida kao modulatori kalijevog kanala
DK2197860T3 (da) Nye forbindelser som adenosin-A1-receptorantagonister
RS51985B (en) NEW IMIDASOLONE DERIVATIVES, THEIR PREPARATION FOR MEDICINES, PHARMACEUTICAL FORM AND THEIR USE AS PROTEIN KINASES SPECIFICALLY CDC7
AR095895A1 (es) Compuestos de acil-imino-piridina n-sustituidos y derivados para combatir plagas de animales
RS51779B (en) MONOLISIN SALTS OF AZOLE COMPOUNDS
AR089880A1 (es) Compuestos fungicidas de pirimidina
AR089881A1 (es) Compuestos fungicidas de pirimidina
SE0101767D0 (sv) Novel compounds
FR2970964B1 (fr) Nouveaux derives d'azacoumarines presentant une activite inhibitrice des pompes mdr
AR103734A1 (es) Heterociclos bicíclicos como inhibidores de fgfr4
DOP2009000040A (es) Derivados de pirrolizina, indolizina y quinolizina, su preparacion y su aplicacion en terapeutica
TH106984B (th) อนุพันธ์ n-ออกไซด์ ไพราซีนที่ถูกแทนที่แล้ว